


Immunopathology of Hyperinflammation in COVID-19
The randomized, controlled, open-label RECOVERY trial (Dexamethasone in Hospitalized Patients with Covid-19--preliminary report) 78 evaluated the efficacy of the corticosteroid dexamethasone (n = 2104) versus usual care (n = 4321) in hospitalized COVID-19 patients. Dexamethasone 6 mg once daily was given for up to 10 days.
